SCHEMBL4934849

SCHEMBL4934849

Nc1ccn([C@@H]2O[C@H](COC(=O)CCCCCCCCCC=O)[C@@H](O)C2(F)F)c(=O)n1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3A Q14432 3/20 0.60
PDE4D Q08499 1/20 0.60
SLC29A1 Q99808 1/20 0.60
POLA1 P09884 2/20 0.56
ITGB3 P05106 2/20 0.41
ITGAV P06756 2/20 0.41
LMNA P02545 3/20 0.39
THRB P10828 1/20 0.39
MTOR P42345 1/20 0.39
MDM2 Q00987 1/20 0.39
NCOA1 Q15788 1/20 0.39
NCOA3 Q9Y6Q9 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.35
EP300 Q09472 1/20 0.35
POLB P06746 1/20 0.35
P2RY2 P41231 1/20 0.35
CACNA1F O60840 2/20 0.34
ALB P02768 2/20 0.34
MAPT P10636 2/20 0.34
CACNA1D Q01668 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5187388 1.00 PDE3A (0.60) PDE3APDE4DSLC29A1POLA1ITGB3
SCHEMBL4942006 1.00 PDE3A (0.60) PDE3APDE4DSLC29A1POLA1ITGB3
SCHEMBL4935081 1.00 PDE3A (0.60) PDE3APDE4DSLC29A1POLA1ITGB3
SCHEMBL5188355 1.00 PDE3A (0.60) PDE3APDE4DSLC29A1POLA1ITGB3
SCHEMBL4938679 1.00 PDE3A (0.60) PDE3APDE4DSLC29A1POLA1ITGB3
SCHEMBL4941183 1.00 PDE3A (0.60) PDE3APDE4DSLC29A1POLA1ITGB3
SCHEMBL4939657 1.00 PDE3A (0.60) PDE3APDE4DSLC29A1POLA1ITGB3
SCHEMBL4940086 1.00 PDE3A (0.60) PDE3APDE4DSLC29A1POLA1ITGB3
SCHEMBL4938641 0.99 PDE3A (0.61) PDE3APDE4DSLC29A1POLA1ITGB3
SCHEMBL4931963 0.96 PDE3A (0.62) PDE3APDE4DSLC29A1POLA1ITGB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080103110-A1 Compounds DRUG DISCOVERY LABORATORY AS (NO) 2008-05-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080103110-A1 Compounds ATIC, CDA, PAICS PDE3A 2090/4885PDE4D 2811/4885SLC29A1 257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.